➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Medtronic
Dow
Baxter
Harvard Business School

Last Updated: October 26, 2021

DrugPatentWatch Database Preview

Jiangsu Hengrui Med Company Profile


Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for JIANGSU HENGRUI MED, and what generic and branded alternatives to JIANGSU HENGRUI MED drugs are available?

JIANGSU HENGRUI MED has fifteen approved drugs.



Summary for Jiangsu Hengrui Med
US Patents:0
Tradenames:14
Ingredients:13
NDAs:15

Drugs and US Patents for Jiangsu Hengrui Med

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jiangsu Hengrui Med LETROZOLE letrozole TABLET;ORAL 202716-001 May 16, 2013 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Jiangsu Hengrui Med IRINOTECAN HYDROCHLORIDE irinotecan hydrochloride INJECTABLE;INJECTION 090675-001 Dec 16, 2011 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Jiangsu Hengrui Med CASPOFUNGIN ACETATE caspofungin acetate POWDER;INTRAVENOUS 200833-001 Jun 28, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Jiangsu Hengrui Med DAPTOMYCIN daptomycin POWDER;INTRAVENOUS 212022-001 Aug 22, 2019 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Jiangsu Hengrui Med FONDAPARINUX SODIUM fondaparinux sodium INJECTABLE;SUBCUTANEOUS 206812-001 May 15, 2018 AP RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKesson
Moodys
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.